Ferring’s low-volume bowel prep now available in the US — 4 insights

Ferring Pharmaceuticals’ low-volume bowel preparation Clenpiq is now available in the U.S. via prescription.

Advertisement

Here’s what you should know:

1. Clenpiq bowel prep is prescribed ready to drink.

2. The prep received FDA approval in November 2017.

3. New York City-based NYU Langone Health Clinical Professor of Medicine Jonathan Cohen, MD, said, “A safe, effective and well-tolerated bowel prep is an important step towards a successful colonoscopy. Patients now have the option of a ready-to-drink, low volume bowel prep.”

4. Ferring’s CEO Paul Navarre said the bowel prep will strengthen the company’s U.S. portfolio.

More articles on gastroenterology: 
Regent Surgical Health opens new joint venture ASC & more — 6 ASC company key notes
All 71 new 2017 ASCs by specialty
14 key points on total joint replacements in ASCs for 2018

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.